IC
DAWN

IEQ Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

IEQ Capital’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$683K Buy
+31,854
New +$449K ﹤0.01% 1174
2025
Q3 		– Sell
-27,948
Closed -$182K – 1902
2025
Q2 		$182K Sell
27,948
-9,064
-24% -$62.4K ﹤0.01% 1632
2025
Q1 		$294K Buy
+37,012
New +$399K ﹤0.01% 1198

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

IEQ Capital's DAWN Position: Q1 2026 in Review

IEQ Capital opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 31,854 shares worth $683K. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings. This is a return to the name: IEQ Capital previously reported a position in DAWN as recently as Q2 2025.

IEQ Capital first reported a position in DAWN in Q1 2025 and has held it in 3 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • IEQ Capital held 31,854 shares of Day One Biopharmaceuticals worth $683K as of Q1 2026.
  • Day One Biopharmaceuticals was a new IEQ Capital position in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1174 holding.
  • IEQ Capital first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.